4//SEC Filing
Sigal Nolan Howard 4
Accession 0000899243-22-023139
CIK 0001420565other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:12 PM ET
Size
5.4 KB
Accession
0000899243-22-023139
Insider Transaction Report
Form 4
Sigal Nolan Howard
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+54,500→ 54,500 totalExercise: $0.40Exp: 2032-06-14→ Common Stock (54,500 underlying)
Footnotes (1)
- [F1]This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders.
Documents
Issuer
AILERON THERAPEUTICS INC
CIK 0001420565
Entity typeother
Related Parties
1- filerCIK 0001323291
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:12 PM ET
- Size
- 5.4 KB